What question did this study set out to answer?

To evaluate how platelet activation, platelet-activating factor (PAF), and thromboxane contribute to arrhythmias, haemodynamic collapse, and myocardial necrosis during acute coronary occlusion.

May 1, 1991European Heart Journal

Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia

View Full Paper

Ask AI

Bookmark

Why the study?

Does inhibition of platelet activity or platelet-activating factor reduce necrosis, hypotension, and arrhythmias in a rabbit model of acute myocardial ischaemia?

Population

Rabbits subjected to acute myocardial ischaemia via coronary ligation for 30 minutes

Comparison

Platelet antiserum, platelet activating factor… vs Control

Design

Preclinical

Follow-up

30 minutes

Authors

SCS. ChakrabartyGreen University of Bangladesh PTPhilip ThomasChristian Medical College, Vellore DSDesmond J. SheridanElectrophysiology

Discussion

Member takes

Implication

Supports platelet role in ischemia-induced necrosis; hypothesis-generating for antiplatelet strategies in acute MI, requiring clinical validation.

Key Points

To evaluate how platelet activation, platelet-activating factor (PAF), and thromboxane contribute to arrhythmias, haemodynamic collapse, and myocardial necrosis during acute coronary occlusion.
Anaesthetized rabbits were subjected to coronary artery ligation for 30 minutes to model acute myocardial ischaemia.
Animals received interventions including platelet depletion (<1% of control) via platelet antiserum (1 ml kg-1 i.v.), the PAF antagonist BN 52021, the thromboxane antagonist CGS 13080, or exogenous PAF administered 10 minutes post-ligation.
Platelet depletion via antiserum significantly reduced the volume of necrotic left ventricular tissue from 23 ± 2% to 15 ± 1% (P < 0.01) and attenuated ischaemia-induced hypotension.
Pretreatment with the PAF antagonist BN 52021 decreased necrosis from 23 ± 2% to 14 ± 1% (P < 0.01), whereas exogenous PAF markedly increased necrosis to 36 ± 2% (P < 0.01) and caused ventricular fibrillation and haemodynamic collapse in 10 out of 12 animals.
Pretreatment with platelet antiserum or BN 52021 completely reversed PAF-induced necrosis and ventricular fibrillation, whereas the thromboxane antagonist CGS 13080 reduced hypotension but failed to prevent necrosis or arrhythmogenesis.

Structured PICO

Does inhibition of platelet activity or platelet-activating factor reduce necrosis, hypotension, and arrhythmias in a rabbit model of acute myocardial ischaemia?

Population

Rabbits subjected to acute myocardial ischaemia via coronary ligation for 30 minutes

Intervention

Platelet antiserum (1 ml kg-1 i.v.), platelet activating factor (PAF) antagonist BN 52021, or thromboxane antagonist CGS 13080

Comparator

Control

Outcome

Volume of necrosed tissuesurrogate

Inhibition of platelet activity or platelet-activating factor reduces myocardial necrosis and hypotension in a rabbit model of acute myocardial ischaemia, supporting the role of platelet inhibition in acute myocardial infarction.

Cite This Study

Chakrabarty et al. (1991) studied this question.

synapsesocial.com/papers/6a9245a2ca631ded64675bf5 https://doi.org/10.1093/oxfordjournals.eurheartj.a059944

View Full Paper

Ask AI

Bookmark

Implication

Supports platelet role in ischemia-induced necrosis; hypothesis-generating for antiplatelet strategies in acute MI, requiring clinical validation.

Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider